-
Signature
-
/s/ Samantha Lagocki, POA
-
Stock symbol
-
EQIX
-
Transactions as of
-
Dec 2, 2024
-
Transactions value $
-
-$2,851,209
-
Form type
-
4
-
Date filed
-
12/3/2024, 06:48 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EQIX |
Common Stock |
Options Exercise |
$0 |
+5.65K |
+1455.15% |
$0.00 |
6.03K |
Dec 2, 2024 |
Direct |
|
transaction |
EQIX |
Common Stock |
Sale |
-$1.16M |
-1.21K |
-20.04% |
$959.35 |
4.83K |
Dec 3, 2024 |
Direct |
F1, F2 |
transaction |
EQIX |
Common Stock |
Sale |
-$227K |
-236 |
-4.89% |
$960.41 |
4.59K |
Dec 3, 2024 |
Direct |
F3 |
transaction |
EQIX |
Common Stock |
Sale |
-$115K |
-120 |
-2.61% |
$961.28 |
4.47K |
Dec 3, 2024 |
Direct |
F4 |
transaction |
EQIX |
Common Stock |
Sale |
-$459K |
-477 |
-10.67% |
$962.70 |
3.99K |
Dec 3, 2024 |
Direct |
F5 |
transaction |
EQIX |
Common Stock |
Sale |
-$408K |
-423 |
-10.6% |
$963.89 |
3.57K |
Dec 3, 2024 |
Direct |
F6 |
transaction |
EQIX |
Common Stock |
Sale |
-$482K |
-500 |
-14.01% |
$964.83 |
3.07K |
Dec 3, 2024 |
Direct |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EQIX |
Restricted Stock Unit |
Options Exercise |
$0 |
-5.65K |
-25% |
$0.00 |
16.9K |
Dec 2, 2024 |
Common Stock |
5.65K |
$0.00 |
Direct |
F8, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: